A conjugate (lz51-BH-SP) between substance P and lz51-labeled Bolton-Hunter reagent binds reversibly to a single class of high affinity (Kd = 4 nM) binding sites on dispersed rat parotid cells. The total number of binding sites is 49 + 17 fmol/mg of protein. The binding affinity of 13 fragments and analogs of substance P correlates with their relative potency in stimulating salivation. The smallest fragment of substance P which exhibits significant binding affinity and saliva-stimulating activity is the COOH-terminal hexa(6-1l)peptide. Structurally unrelated neurotransmitters and hormones do not affect the parotid cell binding of lz51-BH-SP. lz51-BH-SP pre-bound to the cells was recovered mainly in the particulate fractions of the cell homogenate. The '251-BH-SP binding activity of the parotid cells was inactivated by pretreatment of the cells with papain but not with ribonuclease A or deoxyribonuclease I. Our results suggest that '251-BH-SP binds to a substance P receptor on parotid membranes and that the receptor, at least in part, may be a protein.
Substance P is present in the central nervous system and in nerve fibers of most peripheral tissues (Pernow, 1980; Nicoll et al., 1980; Nilsson and Brodin, 1977; Hokfelt et al., 1977) . Substance P neurons may constitute as many as 20% of all neurons in the spinal ganglia (Hokfelt et al., 1977) and 11% of neurons in the submucous plexus of the ileum (Costa et al., 1980) . The undecapeptide exerts many pharmacological actions, including salivation (Leeman and Hammers&lag, 1967; Liang and Cascieri, 1979) , vasodilation (Tregear et al., 1971) , intestinal contraction (Tregear et al., 1971; Bury and Mashford, 1977) , and depolarization of certain neurons (Konishi and Otsuka, 1974; Phillis and Limacher, 1974; Ogata, 1979) . Although the physiological functions of substance P have not been determined, its role as a neurotransmitter/modulator has been implied from histochemical, electrophysiological, and pharmacological studies. Substance P may exert its actions by first interacting with a receptor which is poorly understood.
We have reported previously our initial studies showing specific binding of a conjugate between substance P (SP)' and 1251- to dispersed rat parotid cells (Liang and Cascieri, 1980 a-MSH, a-melanocyte-stimulating hormone; P, the 500 x g pellet of the sonicated cells; S, the 500 x g supernatant of the sonicated cells, SP, substance P; TRH, thyrotropinreleasing hormone.
suggest that the radioactive conjugate may bind to a substance P receptor on parotid membranes.
Materials
and Methods Synthetic substance P, physalaemin, [Metlenkephalin, neurotensin, bradykinin, and angiotensin II were purchased from Beckman. Substance P free acid, substance P methyl ester, [Arglvasopressin, and eledoisin were from Bachem, and chymostatin and eledoisin-related peptide were from the Protein Research Foundation in Osaka, Japan. Deca(B-1l)substance P, nona (3-11)-substance P, octa(4-1l)substance P, [pyroGlu']hexa(G1l)substance P, penta(7-1l)substance P, tetra(B1l)substance P; tri(9-1l)substance P, nona( l-9)substance P, [n-Ala']hepta(5-1l)substance P, kassinin, and ranatensin were purchased from Peninsula. Hepta(5-1l)substance P and somatostatin were kindly provided by Drs Monoiodinated '251-Bolton-Hunter reagent, which was 1500 Ci/mmol at the time of purchase and used within 1 month, was purchased from Amersham.
Preparation of '251-BH-substance P. '251-BH-SP was prepared as previously described Cascieri, Vol. 1, No. 10, Oct. 1981 1980) with minor modifications. Monoiodinated 1251-Bolton-Hunter reagent (1 mCi) was flushed with nitrogen to evaporate the solvent. Substance P (5 pg in 20 1.11 of 0.1 M sodium borate, pH 8.5, and 1.3 mM acetic acid) was added to the tube and was incubated at 0°C for 1 hr. The reaction mixture was purified by thin layer chromatography on Whatman K6 plates in 1-butanol:pyridine: acetic acid:water (v/v, 4:1:1:2). The recovery and extraction of the '""I-BH-SP from the silica gel was carried out in anaerobic conditions as previously described to avoid oxidation of the methionine residue (Liang and Cascieri, 1980) . The molarity of lZ51-BH-SP shown in each experiment was calculated from the radioactivity after being corrected for decay and assuming 80% radiopurity (Liang and Cascieri, 1980) . Preparation of nonradioactive BH-SP. Monoiodinated N-succinimidyl-3-(4-hydroxyphenyl)propionate was prepared as described by Bolton and Hunter (1973) except that Na12"I was replaced with KI in the reaction. For conjugation, the reagent (0.9 pmol) was incubated with substance P (0.74 pmol) in 0.1 M borate buffer, pH 8.5, at 0°C for 60 min in a final volume of 0.15 ml. The reaction mixture in three equal aliquots was chromatographed as described in the previous section. The plate was scraped into 0.5-cm fractions and each fraction was extracted with 0.4 ml of 15% pyridine, 50 mM mercaptoethanol. An aliquot (0.05 ml) of the extract was assayed for saliva-stimulating activity in rats (procedures are described in a later section). Two major biologically active peaks were observed, one co-migrating with ninhydrin-positive substance P and the other co-migrating with ""I-BH-SP . The conjugate (BH-SP) fractions were pooled and the concentration was determined by amino acid analysis. Dansylation of the conjugate produced only dansyl lysine, whereas dansylation of substance P produced both the lysine and arginine derivatives, suggesting that the conjugation is at the a-NH2-terminal.
Cell binding assay. The binding of lz51-BH-SP to parotid cells was measured as before (Liang and Cascieri, 1980) . Briefly, parotid cells, isolated by collagenase treatment of the minced gland (Liang and Cascieri, 1979) , were incubated with '251-BH-SP (0.2 to 0.4 nM) in 0.3 ml of Krebs-Ringer phosphate buffer (120 InM NaCl, 4.8 mM KCl, 1.2 mM CaC12, 1.2 mM MgSO+ and 15.6 mM sodium phosphate, pH 7.0) supplemented with 200 pg/ml of crystalline bovine serum albumin and 50 pg/rnl of chymostatin. When indicated, competing compounds in 3 ~1 of 0.1 M acetic acid or dimethyl sulfoxide were included. After incubation, 0.1 ml was layered on 0.3 ml of 10% sucrose in Krebs-Ringer phosphate buffer and centrifuged for 1 min in a Beckman Microfuge to pellet the cells. The tubes were frozen in an acetone/dry ice bath and the tips were cut with a razor and counted in a Packard Gamma Counter with 71% counting efficiency. Other conditions are specified in individual experiments. Experiments were carried out in duplicate.
Salivation assay. The assay was a modification (Liang and Cascieri, 1979) of the procedure of Leeman and Hammers&lag (1967) . Peptides were dissolved in 0.1 N acetic acid and were diluted in 0.15 M NaCl to the desired concentration immediately before injection. SpragueDawley male rats (body weight, 300 to 350 gm) were anesthetized with ether. The peptide solution (0.1 ml) was injected via a tail vein and saliva was collected immediately from the buccal cavity with a Pasteur pipette over a period of 2 min. The volume of saliva was measured by pipette. Three to five rats were used at each dosage level. Basal release of saliva was determined by injection of the vehicle alone.
Characterization of '251-BH-SP bound to parotid cells. Parotid cells (5 mg of protein) were incubated with ""I-BH-SP (2,110,OOO dpm) in 3 ml of Krebs-Ringer phosphate buffer, pH 7.0, supplemented with 200 pg/ml of bovine serum albumin and 50 pg/rnl of chymostatin in the presence or absence of 2.5 PM substance P. After 20 min at 2O"C, '251-BH-SP bound to the cells was determined on a O.l-ml aliquot as above. The remainder of the cell suspension was centrifuged at 900 x g for 20 sec. The cell pellet was washed twice with 10 ml of ice cold Krebs-Ringer phosphate buffer. Finally, the cell pellet was resuspended in 2.1 ml of cold Krebs-Ringer phosphate buffer with bovine serum albumin and chymostatin. The cells in 0.7 ml of this suspension were pelleted at 900 x g for 20 sec. The remainder of the suspension was sonicated for 1 min and then centrifuged at 500 x g for 10 min. The cell pellet (C) and the 500 x g pellet of the sonicated cells (P) were suspended in 0.5 ml of 50% pyridine plus 50 mru mercaptoethanol and extracted at 0°C for 1 hr. Aliquots of C and P and the 500 x g supernatant (S) of the sonicated cells were "spiked" with 70,000 dpm of authentic '251-BH-SP during this extraction to ascertain the stability of 1251-BH-SP in this and subsequent steps. After 60 min, C, P, and S were centrifuged at 1500 x g for 10 min. The supernatants were counted to determine the extent of extraction (90%) and then evaporated under nitrogen. C, P, and S were taken up in 20 ~1 of 50% pyridine plus 50 mM mercaptoethanol and chromatographed on thin layer plates as described above.
Enzyme treatment of cells. Parotid cells (0.5 mg of protein) were incubated in 2 ml of Krebs-Ringer phosphate buffer, pH 7, and 10 mM cysteine with or without enzymes (180 pg of papain, 50 pg of deoxyribonuclease I, 50 pg of ribonuclease A, 34 pg of phospholipase C, or 20 pg of phospholipase A) for 20 min at 20°C. The cells then were diluted with ice cold Krebs-Ringer phosphate buffer (5 ml) and centrifuged at 900 x g for 20 sec. The cell pellet was washed three times with 5 ml of cold KrebsRinger phosphate buffer, suspended in 1 ml of KrebsRinger phosphate buffer plus 200 pg/rnl of bovine serum albumin and 50 pg/rnl of chymostatin, and then used immediately to measure the binding of 12"1-BH-SP. Papain was activated by incubation with 10 mM cysteine at 20°C for 30 min prior to the addition of the cells.
Under the conditions used in the cell treatment (20 min at 20°C in 2 ml of Krebs-Ringer phosphate buffer, pH 7), deoxyribonuclease I and ribonuclease A hydrolyzed greater than 70% of 250 I-18 of DNA and RNA, respectively.
L-a-Palmitoyl-2-oleoyl-[14C]phosphatidylcholine (0.02 PCi, 55 mCi/mmol; Applied Science Laboratories) was hydrolyzed 90% and 80% by phospholipase C and phospholipase A, respectively.
Protein determination. Cells were either sonicated or homogenized and the protein concentration was deter- mined by the method of Bradford (1976) using bovine y-globulin as the standard.
Results
Parotid cell preparations readily degrade ""I-BH-SP; therefore, in order to demonstrate specific binding of lz51-BH-SP to parotid cells, it is necessary to perform the experiments in the presence of chymostatin using low concentrations of cells at moderately low temperatures (18 to 25°C). Figure 1 shows the time course of '251-BH-SP binding to collagenase-dispersed parotid cells using two levels (2 and 3.8 X 10-l' M) of lz51-BH-SP. The binding is rapid and reaches a maximum level between 10 and 20 min and decreases after 30 min. The binding in the presence of 2.5 pM substance P is much lower, does not change during the period (3 min to 2 hr) of incubation, and is referred to as nonspecific binding. Figure 2 shows a representative experiment showing the dose-dependent inhibition of 1251-BH-SP binding to the cells. The inhibition reaches a plateau between 0.25 and 2.5 PM substance P. The binding that can be inhibited by 2.5 PM substance P is referred to as specific binding and is 85% to 95% of the total. Time course studies carried out at 0°C and at 37°C showed that maximum specific binding was only 10% and 30%, respectively, of that at 2O'C. The binding studies to be described below were carried out at approximately 20°C for 20 min. The cell-bound radioactivity can be extracted with 50% pyridine and at least Inhibition of parotid cell binding of '251-BH-SP by substance P. Isolated parotid cells (1.04 mg of protein) were incubated with '251-BH-SP (282,000 dpm, 3.3 X 10-l' M) and substance P at the concentrations indicated on the abscissa. The final volume was 0.3 ml. After 25 min at 25"C, 0.1 ml of the incubation mixture was removed for dete rmining the amount of radioactivity bound to the cells. 1136 Liang and Cascieri Vol. 1, No. 10, Oct. 1981 80% of the radioactivity extracted co-chromatographed with ""I-BH-SP (data not shown). These results suggest that parotid cells reversibly bind intact lz51-BH-SP. Figure 3 shows the inhibition of 1251-BH-SP binding to parotid cells by BH-SP which is radio-inert but otherwise identical to '""I-BH-SP. Scatchard analysis of these data indicates that the parotid cells appear to have a single type of specific binding site. The apparent dissociation constant (&) is 4.0 f 1.8 nM (mean f SD, four experiments) with 49 f I7 fmol of binding sites per mg of protein. The number of binding sites per cell was not determined since the cell preparation still contains undispersed lobules which precludes an accurate determination of the cell number. Complete cell dispersion could be achieved by using more strenuous conditions during tissue digestion (e.g., 5 mg/ml of collagenase at 37°C for 1 l-n-), however, such preparations were unresponsive to substance P (Liang and Cascieri, 1979) .
In a series of experiments, various fragments and analogs of substance P were titrated for their ability to inhibit the parotid cell binding of '251-BH-SP in order to determine if their binding affinities correlate with their potency in stimulating salivation in rats. Figure 4 summarizes the results of the competition of the cell binding of ""I-BH-SP by fragments of substance P. The potency of the fragments of substance P decreases as the chain length decreases from the NHa-terminal. The smallest fragment of substance P which exhibits significant inhibitory activity is the hexa(6-1l)peptide. Further decreases in the chain length drastically decrease potency. Thus, the penta(7-1l)peptide is a very weak competitor; the tetra(8-ll)-and the tri(9-ll)peptides, even at very high concentrations, do not compete for the cell binding of 'e*, Bound (f moV100pl) Figure   3 . Inhibition of parotid cell binding of '""I-BH-SP by radio-inert BH-SP and Scatchard analysis of the binding. Left, Parotid cells (0.7 mg of protein) were incubated with lz51-BH-SP (214,000 dpm, 2 X lo-" M) and various concentrations of nonradioactive BH-SP in a final volume of 0.3 ml. After 25 min at 25"C, 0.1 ml of the incubation mixture was removed to determine cell-bound radioactivity. The binding in the presence of 2.5 IJ.M substance P (i.e., nonspecific binding) also was determined (172 dpm) and this value was subtracted. Right, Scatchard analysis of the data on the left. From this and three similar experiments, the apparent dissociation constant (&) was calculated to be 4.0 + 1.8 nM (Kd = -l/slope) and the number of total binding sites calculated from the abscissa was 49 f 17 fmol/mg of protein (mean f SD).
Peptide
(M ) Figure   4 . Competition of parotid binding of '*"I-BH-SP by substance P and its fragments. Substance P: Arg'-Pro-Lys"-ProGin'-Gln-Phe7-Phe-Glyg-Leu-Met"-NHz. lz51-BH-SP (211,000 dpm) was incubated with parotid cells (0.5 mg of protein) in the absence and presence of a competing peptide in a final volume of 0.3 ml at 20°C for 20 min. After incubation, 0.1 ml was removed to determine the cell-bound radioactivity. The specific binding was calculated by subtracting the binding in the presence of 2.5 PM substance P from the total binding. The specific binding in the absence of a competitor was taken as 100%. The bars indicate the standard deviation in the number of experiments given in Table I. lz51-BH-SP. Deamidated substance P (substance P free acid) has a binding affinity three orders of magnitude lower than that of substance P. The nona(l-9)peptide is a much weaker competitor. The concentrations of these peptides required to inhibit the cell binding of 12"1-BH-SP by 50% (IC& were estimated from their titration curves and are listed in Table I . Not included in the figure is a hepta(5-11) fragment preparation consisting of 50% pyroglutamyl and 50% glutamyl residues at the NHQ-terminal which has an inhibitory potency similar to the octa(4-1l)peptide.
The cell binding of 1251-BH-SP could be inhibited by biologically active analogs of substance P and their values of IC50 are listed in Table I . Physalaemin and the conjugate (BH-SP) between substance P and the radio-inert Bolton-Hunter reagent both are slightly more potent competitors than substance P. Substance P methyl ester, a biologically active analog (Cascieri et al., 1981) in which the COOH-terminal amide has been replaced by a methyl ester, is a less potent competitor. [D-Ala']Hepta(5-1l)substance P, eledoisin, kassinin, and eledoisin-related peptide are also effective competitors. Figure 5 shows the dose-dependent stimulation of salivation in ether-anesthetized rats by fragments of substance P. The doses of these peptides required to produce half-maximal stimulation of salivation (ED& were estimated from these curves and are listed in Table I . Other analogs of substance P also were evaluated for their potency to stimulate salivation and their values of ED50 are included in Table I . Physalaemin and BH-SP are slightly more potent than substance P in stimulating salivation. Other peptides are all less potent than substance P. Log (nmoi/lOOg b.w.1 Figure 5 . Stimulation of salivation in rats by substance P and its fragments. The assay is described under "Materials and Methods." The maximum stimulation produced by substance P, considered to be lOO%, was 364 f 39 $/rat (seven experiments) which compared to a basal level of 2 k 1.6 pi/rat. Not included in the figure are data for the tetra(8-ll)-and tri(9-1l)peptides which had no effect on salivation up to the highest concentration tested (50 nmol/lOO gm of body weight (g bm.)).
results. Excellent correlation between the relative receptor binding affinity and the relative saliva-stimulating potency was obtained with physalaemin, BH-SP, DAla"(5-11), octa(4-11), SP methyl ester, (l-1l)free acid, and penta(7-11). However, eledoisin and hexa(pyroGlu"-11) exhibited a greater (15-and 34-fold, respectively) potency in stimulating salivation than their relative receptor affinity would predict, whereas the deca(2-ll)-and nona(3-1l)peptides have a receptor binding affinity about 7-to lo-fold higher than their saliva-stimulating potency. Nevertheless, the overall correlation is good (correlation coefficient, 0.92). Table II summarizes a representative experiment showing the subcellular distribution of the radioactivity pre-bound to the cells. A comparison of the radioactivity in the respective fractions between 1251-BH-SP bound in the absence and in the presence of substance P (2.5 PM) indicates that the radioactivity in all three particulate fractions decreased to a much greater extent than did the cytosol fraction when substance P was present in the binding incubation. Seventy-six percent of the specific binding was recovered in the 500 x g pellet. In one experiment, the radioactivity in the 500 x g pellet was extracted with pyridine (50%) and 80% of the radioactivity co-chromatographed with authentic lz51-BH-SP on thin layer chromatography. These results suggest that the specific binding site is mainly, if not entirely, present in membranes. Table III shows that pretreatment of the cells with papain at 20°C for 15 min decreases '251-BH-SP binding Figure  4 . The doses of the peptides required to stimulate 50% of maximum (ED,) salivation in rata were estimated from titration curves such as those in Figure 5 . Some peptides at the dosages tested did not reach 50% maximum effect and their I& and ED:*, were estimated by extrapolation of the curves. Where possible, the values of ICXx, and EDm are given as the mean + SD of the number of experiments shown in parentheses. The relative receptor binding affinity and the relative potency for salivation were calculated by comparisons of IC, and ED?,,, values, respectively, with those of substance P. The amino acid sequences of substance P analogs are: physalaemin, pyroGlu-AlaAsp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NHz; eledoisin, pyroGlu-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH~; kassinin, Asp-Val-Pro-LysSer.Asp-Gln-Phe-Val-Gly-Leu-Met-NH*;
and eledoisin-related peptide, Lys-Phe-Ile-Gly-Leu-Met-NH2. Figure 6 . Correlation between the relative binding affinity to rat parotid cells and the relative saliva-stimulating activity for substance P-related peptides. The data are taken from Table I and their log values are plotted. The line is the theoretical correlation of 1.0. The correlation coefficient calculated from these data is 0.92 with a slope of 1.01. be a protein. Pretreatment of the cells with deoxyribonuclease I or pancreatic ribonuclease A does not affect the binding (Table III) . The effect of phospholipase A and phospholipase C treatment was variable and no conclusion can be made at the present time.
Structurally unrelated peptides and amines tested at concentrations up to 10 or 100 PM did not show any significant effect on the parotid cell binding of iz51-BH-SP. These are somatostatin, bradykinin, ranatensin, (Y-MSH, angiotensin II, neurotensin, TRH, epinephrine, acetylcholine, atropine, carbachol, and baclofen (Table  IV) . ACTH, LHRH, [Arglvasopressin, and [Metlenkephalin have been previously shown to have no effect (Liang and Cascieri, 1980) . buffer, pH 7.0, containing bovine serum albumin (200 pg/ml) and chymostatin (50 pg/ml) in a final volume of 6 ml. After 30 min at 2O"C, 0.1 ml of the incubation mixture was taken to determine cell-bound radioactivity. The remainder was centrifuged at 900 X g for 20 set and the cell pellet was washed with 10 ml of ice cold Krebs-Ringer phosphate buffer, pH 7.0, containing bovine serum albumin. The washed cell pellet was suspended in 5 ml of ice cold Krebs-Ringer phosphate buffer, pH 7.0, and homogenized with a motor-driven Potter-Elvehjem glassglass homogenizer (Kontes; 25 strokes). Examination of the cells before and after homogenization under a microscope showed that about 95% of the cells were broken by the homogenization. The homogenate was fractionated by differential centrifugation at 500 x g for 10 min, 10,000 x g for 10 min, and 300,090 x g for 60 min. Discussion Acylation of the NHn-terminal of substance P with Bolton-Hunter reagent, which has been widely used to label peptides (Langone, 1980) , produces a conjugate which is slightly more potent than substance P in stimulating salivation and which has high affinity for a substance P binding site on the rat parotid cells. A good correlation was observed between the relative binding affinity of substance P fragments and analogs and their relative saliva-stimulating activity. Although the parotid gland is only one of the tissues involved in salivation, Hanley et al. (1980a) and Brown and Hanley (1981) have reported a good correlation between the relative potency of substance P fragments in stimulating salivation and their relative potency in stimulating the incorporation of [3H]inositol into phosphatidylinositol in parotid fragments and in stimulating amylase release from parotid gland slices, respectively. Thus, lZ51-BH-SP may bind to a substance P receptor on the parotid cells.
Among reports (Hanley et al., 1980b; Nakata et al., 1978; Sjodin et al., 1980; Jensen and Gardner, 1979; Putney et al., 1980) attempting to demonstrate the binding of radioactive ligands to the substance P receptor, our system exhibits higher total binding (disintegrations per min per mg of protein) and lower nonspecific binding than others. The nonspecific binding (i.e., '251-BH-SP binding which is not inhibited by excess substance P (micromolar)) in our system is only 5% to 15% of the total binding. This compares favorably with the reported nonspecific binding of 40% to 50% for [3H]substance P binding to rat brain membranes (Hanley et al., 1980b) , about 30% for C3H]substance P binding to rabbit brain membranes (Nakata et al., 1978) , 38% for [1251-Tyrs]substance P binding to guinea pig pancreatic cells (Sjodin et al., 1980) , about 25% for '251-physalaemin binding to guinea pig pancreatic cells (Jensen and Gardner, 1979) , and 78% for '251-physalaemin binding to rat parotid cells (Putney et al., 1980) . We have compared the binding of [1251-Tyr8]substance P (from New England Nuclear) to rat parotid cells with that of '251-BH-SP. ['251-Tyr8]Substance P showed lower total binding and higher nonspecific binding than did 1251-BH-SP. As a result, the specific binding of [1251-Tyra]substance P was only 30% of that of 1251-BH-SP.
It is known that substance P is readily oxidized to substance P (methionine) sulfoxide upon exposure of a dilute solution even to air (Floor and Leeman, 1980) . Preparation of 1251-physaIaemin and [ 1251-Tyra]substance P involves exposure of the peptides to chloramine T which might oxidize the methionine residue. The oxidized peptides may have a lower affinity for the substance P receptor and may bind to nonreceptor sites more readily. We have noticed that lz51-BH-SP exposed to air during purification (particularly during the scraping and extraction from the silica gel) exhibits variable binding to parotid cells. Upon rechromatography of such a preparation, an additional peak was observed which moved between lz51-BH-SP and substance P. This additional radioactive peak was converted to '251-BH-SP upon incubation with 2 M dithiothreitol at 80°C for 2 hr, a condition known to convert substance P sulfoxide to substance P (Floor and Leeman, 1980) . Thus, it is essential to prepare '251-BH-SP under anaerobic conditions.
Among reports attempting to demonstrate the binding of radioactive ligands to the substance P receptor, only [3H]substance P binding to the rabbit (Nakata et al., 1978) and rat brain membranes (Hanley et al., 1980b) were characterized extensively by competition with fragments of substance P. Interestingly, (pyroGlu'-1l)substance P has a binding affinity 1.7-fold that of substance P in rat brain membranes and only 0.005-fold that of substance P in our parotid cell binding, whereas the deca(2-11), nona(3-11), and octa(4-11) fragments and physalaemin have a remarkably similar potency in these two systems. (pyroGlu'-1l)Substance P also has been reported to be more potent than substance P (5-to 12-fold) in depolarizing rat spinal neurons (Otsuka and Konishi, 1977) , but it is less potent than substance P (0.17-fold) in stimulating salivation as reported here and 1140 Liang and Cascieri Vol. 1, No. 10, Oct. 1981 by others (Hanley et al., 1980a; Leeman et al., 1977) . Although other explanations are possible, it is tempting to speculate that the substance P receptor in the nerve tissues may not be identical to that in the parotid gland. Multiple types of receptors for histamine (Hirschowitz, 1979) and epinephrine (Kunos, 1976) have been documented.
Our data suggest that '""I-BH-SP binds to a membrane receptor for substance P (Table II) . We are carrying out autoradiographic studies in order to determine whether '""I-BH-SP binds to the cell surface membrane or to intracellular membranes. Preliminary results indicate that, after the incubation of cells with lZ51-BH-SP at 20°C for 20 min, the silver granules were present mainly on the surface of acinar cells. The cell surface granules largely disappeared when substance P (2.5 pM) was included in the binding incubation. Thus, 1251-BH-SP may bind to a cell surface receptor.
Although phospholipids have a high affinity for [lZ51-Tyr"]substance P (& = 0.3 nM; Mayer et al., 1979; Lembeck et al., 1979) , the ligand specificity is not that expected for receptor binding since physalaemin, [Tyr'lsubstance P, and eledoisin, all potent analogs of substance P (Konishi and Otsuka, 1974; Rosell et al., 1977) , do not inhibit the binding. We provide a preliminary indication that the substance P receptor on the parotid cells may involve a protein. However, further studies are required to determine the chemical nature of the receptor.
We estimate that the number of substance P binding sites on rat parotid cells is 49 + 17 fmol/mg of protein which is significantly higher than that reported (1.67 fmol/mg of protein or 200 sites/cell) by Putney et al. (1980) . The major differences between the two systems is that they used '251-physalaemin prepared by the chloramine T method and their binding incubation was carried out at a higher temperature (37°C) in the absence of protease inhibitors. It is conceivable that a major portion of the ""I-physalaemin preparation is in the sulfoxide form. In addition, higher temperatures facilitate degradation of the radioactive ligand during the binding incubation. The higher nonspecific binding (78% of total) and low total binding using '251-physaIaemin may result in an underestimation of the number of specific binding sites.
12"1-BH-SP binding to the parotid cells should be a useful system for screening for substance P agonists and antagonists and "'I-BH-SP may also be used to characterized the substance P receptor in other tissues.
